FI973530A0 - Tetraliineja - Google Patents

Tetraliineja

Info

Publication number
FI973530A0
FI973530A0 FI973530A FI973530A FI973530A0 FI 973530 A0 FI973530 A0 FI 973530A0 FI 973530 A FI973530 A FI 973530A FI 973530 A FI973530 A FI 973530A FI 973530 A0 FI973530 A0 FI 973530A0
Authority
FI
Finland
Prior art keywords
tetra
liner
tetra liner
Prior art date
Application number
FI973530A
Other languages
English (en)
Swedish (sv)
Other versions
FI973530A (fi
Inventor
Robert Swoboda
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10774032&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI973530(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI973530A0 publication Critical patent/FI973530A0/fi
Publication of FI973530A publication Critical patent/FI973530A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/48Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI973530A 1995-05-05 1997-08-27 Tetraliineja FI973530A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9509156.7A GB9509156D0 (en) 1995-05-05 1995-05-05 Organic compounds
PCT/EP1996/001841 WO1996034849A1 (en) 1995-05-05 1996-05-03 Tetralines bearing a phenyl substituant on the aromatic ring and their use in the treatment of epilepsy, stroke and brain or spinal trauma

Publications (2)

Publication Number Publication Date
FI973530A0 true FI973530A0 (fi) 1997-08-27
FI973530A FI973530A (fi) 1997-11-04

Family

ID=10774032

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973530A FI973530A (fi) 1995-05-05 1997-08-27 Tetraliineja

Country Status (33)

Country Link
US (1) US6169116B1 (fi)
EP (1) EP0823892B1 (fi)
JP (1) JP3194965B2 (fi)
KR (1) KR100435009B1 (fi)
CN (1) CN1122019C (fi)
AR (1) AR004484A1 (fi)
AT (1) ATE193884T1 (fi)
AU (1) AU706392B2 (fi)
BR (1) BR9608169A (fi)
CA (1) CA2217855C (fi)
CO (1) CO4440486A1 (fi)
CZ (1) CZ292022B6 (fi)
DE (1) DE69608891T2 (fi)
DK (1) DK0823892T3 (fi)
ES (1) ES2148772T3 (fi)
FI (1) FI973530A (fi)
GB (1) GB9509156D0 (fi)
GR (1) GR3033715T3 (fi)
HK (1) HK1014929A1 (fi)
HU (1) HUP9801068A3 (fi)
IL (1) IL118141A (fi)
MX (1) MX9708510A (fi)
NO (1) NO308948B1 (fi)
NZ (1) NZ308471A (fi)
PE (1) PE54797A1 (fi)
PL (1) PL182857B1 (fi)
PT (1) PT823892E (fi)
RU (1) RU2169727C2 (fi)
SK (1) SK282022B6 (fi)
TR (1) TR199701298T1 (fi)
TW (1) TW359667B (fi)
WO (1) WO1996034849A1 (fi)
ZA (1) ZA963540B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60219687T2 (de) * 2001-12-27 2007-12-27 Ortho-Mcneil Pharmaceutical, Inc. Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems
ATE533743T1 (de) * 2002-05-17 2011-12-15 Janssen Pharmaceutica Nv Harnstoffderivate von aminotetralin als modulatoren des vanilloid-rezeptors vr1
WO2005037286A1 (en) 2003-03-25 2005-04-28 Vasopharm Biotech Gmbh Use of pteridine derivatives for the treatment of increased intracranial pressure and secondary ischemia
EP1956006A1 (en) 2007-02-06 2008-08-13 Laboratorios del Dr. Esteve S.A. Heterocyclyl-substituted-tetrahydro-naphthalen derivatives as 5-HT7 receptor ligands
EP1975161A1 (en) 2007-03-28 2008-10-01 Laboratorios del Dr. Esteve S.A. Heterocyclyl-substituted- tetrahydro-napthalen-amine derivatives, their preparation and use as medicaments
WO2008154044A1 (en) * 2007-06-15 2008-12-18 University Of Florida Research Foundation Therapeutic compounds and methods of use
EP2011786A1 (en) * 2007-07-05 2009-01-07 Laboratorios del Dr. Esteve S.A. Indane-amine derivatives, their preparation and use as medicaments
JP6817073B2 (ja) * 2014-05-19 2021-01-20 ノースイースタン ユニバーシティ セロトニン受容体を標的にする化合物および方法
EP4200287A2 (en) * 2020-08-19 2023-06-28 Northeastern University Serotonin receptor modulators

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045179B2 (ja) * 1977-06-08 1985-10-08 フナイ薬品工業株式会社 新規環状アミノアルコ−ル類およびその製造法
EP0257285A3 (en) 1986-07-28 1989-12-27 Whitby Research Incorporated Method and compositions for reducing the intraocular pressure of mammals
DE3718317A1 (de) 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
EP0381902A1 (en) 1989-01-09 1990-08-16 Merrell Dow Pharmaceuticals Inc. Tetralin derivatives
JP2931986B2 (ja) 1989-02-17 1999-08-09 武田薬品工業株式会社 アラルキルアミン誘導体
SE8901889D0 (sv) * 1989-05-26 1989-05-26 Astra Ab Novel 8-substituted-2-aminotetralines
DK0640618T3 (da) * 1993-08-27 2000-04-03 Hoffmann La Roche Tetrahydronaphthalen-peptidderivater
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
PT823892E (pt) 2000-11-30
AR004484A1 (es) 1998-12-16
RU2169727C2 (ru) 2001-06-27
FI973530A (fi) 1997-11-04
NO975087L (no) 1997-11-04
EP0823892A1 (en) 1998-02-18
HUP9801068A2 (hu) 1999-05-28
US6169116B1 (en) 2001-01-02
JP3194965B2 (ja) 2001-08-06
HUP9801068A3 (en) 2000-02-28
IL118141A0 (en) 1996-09-12
BR9608169A (pt) 1999-02-09
WO1996034849A1 (en) 1996-11-07
MX9708510A (es) 1998-03-31
GR3033715T3 (en) 2000-10-31
CA2217855A1 (en) 1996-11-07
PL323037A1 (en) 1998-03-02
AU5812996A (en) 1996-11-21
KR100435009B1 (ko) 2004-08-16
CN1122019C (zh) 2003-09-24
TR199701298T1 (xx) 1998-02-21
AU706392B2 (en) 1999-06-17
KR19990008301A (ko) 1999-01-25
GB9509156D0 (en) 1995-06-28
NO308948B1 (no) 2000-11-20
NZ308471A (en) 1999-01-28
JPH10513479A (ja) 1998-12-22
ZA963540B (en) 1997-11-03
ATE193884T1 (de) 2000-06-15
TW359667B (en) 1999-06-01
CO4440486A1 (es) 1997-05-07
DK0823892T3 (da) 2000-10-02
PE54797A1 (es) 1998-01-21
DE69608891D1 (de) 2000-07-20
PL182857B1 (pl) 2002-03-29
CZ348697A3 (cs) 1998-02-18
SK148597A3 (en) 1998-10-07
DE69608891T2 (de) 2000-11-16
IL118141A (en) 2002-11-10
CZ292022B6 (cs) 2003-07-16
ES2148772T3 (es) 2000-10-16
HK1014929A1 (en) 1999-10-08
EP0823892B1 (en) 2000-06-14
SK282022B6 (sk) 2001-10-08
NO975087D0 (no) 1997-11-04
CN1183763A (zh) 1998-06-03
CA2217855C (en) 2008-12-09

Similar Documents

Publication Publication Date Title
DE69608259D1 (de) Verbunddamenbinde
ATA135896A (de) Skibob
FI973530A0 (fi) Tetraliineja
ATE198470T1 (de) Alkenyl-benzoylguanidine
ATE240972T1 (de) Cyclopeptolide
ATA119896A (de) Scheibenmähwerk
DE59600405D1 (de) Gehhilfe
KR970027656U (ko) 라이너 탈거기
KR960033380U (ko) 조립식 가구
BR9501643A (pt) Helistato
KR970002018U (ko) 건축용 강선고정구
KR970038616U (ko) 라이너 형성구조
BR7500363U (pt) Formulário
BR7501376U (pt) Massarreal
BR7501858U (pt) Tellelight
BR7500703U (pt) Rodopratic
BR7500809U (pt) Tele-negocios
BR7500825U (pt) Chutegol
BR7500838U (pt) Vassourágua
BR7500991U (pt) Caríndio
BR7501298U (pt) Torre-audio-visual
BR9500079A (pt) Bomballoon
BR7501301U (pt) Guarda-chuva-mochila
BR7501303U (pt) Dupla-embalagem
BR7500192U (pt) Parasitofiltro

Legal Events

Date Code Title Description
MA Patent expired